Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms

Urology

Volumn 61, Issue 4, 2003, Pages 864-869

  Rao, Anuradha ^c   Chang, Bao Li ^c   Hawkins, Gregory ^c   Hu, Jennifer J ^c   Rosser, Charles J ^a   Hall, M Craig ^c   Meyers, Deborah A ^c   Xu, Jianfeng ^c   Cramer, Scott D ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ALLELE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME ASSAY; EXPRESSION VECTOR; GENE INTERACTION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENOTYPE; HORMONE RESPONSIVE ELEMENT; HUMAN; IN VITRO STUDY; MALE; NUCLEOTIDE REPEAT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0037382293     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02414-7     Document Type: Article

References (21)

1. Sinha A., Wilson M., Gleason D. Immunoelectron microscopic localization of prostate-specific antigen in human prostate by the protein A-gold complex. Cancer. 60:1987;1288-1293.
2. Schuur E., Henderson G., Kmetec L., et al. Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem. 271:1996;7043-7051.
3. Pang S., Dannulli J., Kaboo R., et al. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res. 57:1997;495-497.
4. Cleutjens K.B., van Eekelen C.C., van der Korput H.A., et al. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem. 271:1996;6379-6388.
5. Cleutjens K.B., van der Korput H.A., van Eekelen C.C., et al. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol. 11:1997;148-161.
6. Huang W., Shostaki Y., Tarr P., et al. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem. 274:1999;25756-25768.
7. Rao A., Cramer S. Identification of a polymorphism in the ARE I region of the PSA promoter (abstract). Cancer Res. 40:1999;60.
8. Edwards A., Hammond H.A., Jin L., et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 12:1992;241-253.
9. Sleddens H.F.B.M., Oostra B.A., Brinkmann A.O., et al. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet. 2:1993;493.
10. Simental J., Sar M., Lane M., et al. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem. 266:1991;510-518.
11. Jenster G., Van der Korput H., Van Vroonhoeven C. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol. 5:1991;1396-1404.
12. Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186.
13. Kazemi-Esfarjani P., Triffino M., Pinsky L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor possible pathogenic relevance for the (CAG)n-expanded neuropathies. Hum Mol Genet. 4:1995;523-527.
14. Irvine R., Ma H., Yu M., et al. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet. 9:2000;267-274.
15. Giovannucci E., Stampfer M.J., Krithivas K., et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. [published erratum appears in Proc Natl Acad Sci USA 94: 8272, 1997] Proc Natl Acad Sci USA. 94:1997;3320-3323.
16. Ingles S.A., Ross R.K., Yu M.C., et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst. 89:1997;166-170.
17. Stanford J.L., Just J.J., Gibbs M., et al. Polymorphic repeats in the androgen receptor gene molecular markers of prostate cancer risk. Cancer Res. 57:1997;1194-1198.
18. Xue W.-M., Coetzee G., Ross R., et al. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 10:2001;575-579.
19. Xu J., Meyers D.A., Sterling D.A., et al. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate specific antigen genes. Cancer Epidemiol Biomarkers Prev. 11:2002;664-669.
20. Weir B. Genetic Data Analysis. II. Methods for Discrete Population Genetic Data. 1996;Sinauer Association, Boston.
21. Zaykin D., Zhivotovsky L., Weir B. Exact tests for association between alleles at arbitrary numbers of loci. Genetica. 96:1995;169-178.